Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07409961

Middle Cerebral Artery Acceleration Time as Indicator in Fetal Anemia

Fetal anemia one of serious fetal problems that may lead in sever cases to fetal demise early detection and precise intervention safe fetal life , traditional evaluation the severity and need of blood transfusion done by middle cerebral artery peak systolic velocity in doppler wave, in this study innovative technique suggested to compared with standard technique

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Fetal Anemia

Age range

18 year–35 year

Sex eligibility

Female

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • fetus with fetal anemia or hyperdynamic state

Exclusion criteria

  • associated fetal congenital anomalies

Treatment and study plan

Primary outcomes

  1. acceleration time in middle cerebral artery doppler

    Time frame: 5 minutes

    time in millisecond in middle cerebral artery waveform from beginning of systole to reaching peak velocity

Study contacts

Contact information is provided by the study sponsor or research team.

Sief Ali

CONTACT

[email protected]

01004971596

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Feb 13, 2026
Registry last updated
Feb 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.